Medical Device CRO Market Growth

The Medical Device CRO Market Growth is Anticipated at a CAGR of 7.9%; Market Value to Grow to USD 43.6 Billion by 2035 | Roots Analysis

According to a recently published report by Roots Analysis, the increasing demand for novel and advanced medical devices coupled with a heightened emphasis on patient safety, and the resource-intensive nature of clinical trial processes has prompted the medical device developers to outsource development and testing processes, thereby creating lucrative opportunities for medical device CROs.

Medical Device CRO Industry Overview

The global medical device CRO market size is estimated to reach USD 43.6 billion by 2035, representing a higher CAGR of 7.9% in the forecast period.

Medical device CROs are specialized organizations that offer technical expertise to medical device companies to conduct research and development activities, such as preclinical studies and clinical research on their behalf on a contractual basis. These organizations play a pivotal role in the development and approval process of medical devices by offering a range of preclinical and clinical services across various study phases, including clinical data management, project management and quality assurance.

Browse 250+ figures and 210+ market data tables and detailed Table of Content on “Medical Device CRO Market” by Class of Medical Device, Type of Medical Device, Scale of Operation, Type of Preclinical Service Offered, Type of Clinical Service Offered, Company Size, Type of Original Equipment Manufacturer, Target Indication, Geographical Regions and Key Players: Industry Trends and Global Forecasts, till 2035” here: https://www.rootsanalysis.com/reports/medical-device-cros-market/226.html

Market Drivers

Several factors are propelling the medical device CRO market growth. One of the key factors driving the future of the medical device CRO market is the heightened demand for advanced and innovative medical devices. CROs offer specialized expertise and scalable solutions that enable medical device companies to accelerate product development timelines and respond effectively to market needs. Additionally, medical device companies tend to outsource preclinical and clinical research operations in order to diversify supply chains and mitigate risks associated with geopolitical instability and economic uncertainties. Further, the growing adoption of advanced technologies, such as cloud-computing and data analytics, improves operational efficiency in the product development process. These technologies facilitate compliance with stringent regulatory requirements, ensuring their clients (medical device companies) maintain a competitive edge and successfully launch their devices to market.

Market Restraints

While the medical device CRO market is experiencing substantial growth, it is not without its challenges. One of the primary restraints is the robust in-house capabilities of medical device companies across various stages of product development. Notably, in-house operations allow medical device companies to maintain stringent control over their product development process, ensuring that all aspects of product design and product development align with their strategic goals. In addition, differences in time zones, language, and cultural nuances can create communication barriers between medical device companies and medical device CROs, These factors may result in misunderstandings or delays, ultimately leading to project setbacks that require extra time and resources to address. Consequently, such challenges pose significant challenge for the medical device CROs.

Growth Factors

Despite the challenges, several factors continue to drive the medical device CRO market growth forward. One notable factor is the stringent regulatory requirements for the approval of class II and class III medical devices. These devices pose significant risk due to the potential serious harm associated with them (if misused). This has prompted medical device companies to seek specialized services to closely monitor the product development process and ensure compliance with regulatory standards. Further, in recent years, medical device companies have shifted their focus towards minimizing the product development cost, leading to outsourcing some / all aspects of medical device development process to CROs. The increased focus on research and development in the MedTech industry, coupled with the above-mentioned factors along with the medical device CRO market is anticipated to witness significant growth in the foreseen future.

Medical Device CRO Market Segments

Based on the class of medical device, the market is segmented into class I, class II and class III medical devices

• The class II medical device segment is likely to capture the largest revenue share of ~50% in the medical device CRO market, in the current year.
• The class III medical device segment is anticipated to be the fastest growing segment in this industry, with an annualized growth rate (CAGR) of 9.3%, during the forecast period.

Based on type of medical device, the market is segmented into MedTech devices, diagnostic devices, handheld diagnostic devices and other devices

• The MedTech devices segment is likely to capture the largest revenue share of 55% in the medical device CRO market, in the current year.
• The diagnostic devices segment is anticipated to be the fastest growing segment in this industry, with an annualized growth rate (CAGR) of 8.7%, during the forecast period.

Based on the scale of operation, the market is segmented into preclinical and clinical scale

• The clinical scale segment is likely to capture the largest revenue share of close to 80% in the medical device CRO market, in the current year.
• The clinical scale segment is anticipated to be the fastest growing segment in this industry, with an annualized growth rate (CAGR) of 8%, during the forecast period.

Based on the type of preclinical service offered, the market is segmented into sterility and microbiology testing, biocompatibility testing, material characterization and analytical testing and other services

• The sterility and microbiology testing segment is likely to capture the largest revenue share of more than 35% in the medical device CRO market, in the current year.
• The biocompatibility testing segment is anticipated to be the fastest growing segment in this industry, with an annualized growth rate (CAGR) of 8%, during the forecast period.

Based on type of clinical service offered, the market is segmented into clinical trial management, data management, regulatory support, consultancy and other services

• The clinical trial management segment is likely to capture the largest revenue share of more than 50% in the medical device CRO market, in the current year.
• The consultancy segment is anticipated to be the fastest growing segment in this industry, with an annualized growth rate (CAGR) of 8.8%, during the forecast period.

Based on the company size, the market is segmented into small, mid-sized and large companies

• The large company segment is likely to capture the largest revenue share of ~70% in the medical device CRO market, in the current year.
• The mid-sized company segment is anticipated to be the fastest growing segment in this industry, with an annualized growth rate (CAGR) of 8.4%, during the forecast period.

Based on the type of original equipment manufacturer, the market is segmented into small and mid-sized OEMs, large OEMs, and very large OEMs

• The very large OEMs segment is likely to capture the largest revenue share of more than 55% in the medical device CRO market, in the current year.
• The small and mid-sized OEMs segment is anticipated to be the fastest growing segment in this industry, with an annualized growth rate (CAGR) of 8.5%, during the forecast period.

Based on target indication, the market is segmented into cardiovascular disorders, oncological disorders, neurological disorders, orthopedic disorders, pain disorders, ophthalmological disorders, psychological disorders, metabolic disorders and other disorders

• The cardiovascular segment is likely to capture the largest revenue share of ~25% in the medical device CRO market, in the current year.
• The other disorders segment is anticipated to be the fastest growing segment in this industry, with an annualized growth rate (CAGR) of 8.9%, during the forecast period.

Based on the regional insights, the market is segmented into North America, Europe, Asia Pacific, Middle East and North Africa, and Latin America

• North America dominated the medical device CRO market and accounted for the largest revenue share (more than 45%) in the current year.
• In Asia Pacific, the medical device CRO market is anticipated to demonstrate lucrative growth during the forecast period.

Companies Profiled

The medical device CRO market report also includes profiles of some players (listed below) that are engaged in the medical device CRO domain:

• Avania
• CSSi LifeSciences
• Eurofins Medical Testing
• IQVIA
• NAMSA
• Qserve Consultancy
• SGS
• UL Solutions

You Can Download Free Sample PDF Copy of This Report At:
https://www.rootsanalysis.com/reports/medical-device-cros-market/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in market research, competitive intelligence and consulting services. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary

Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com